The high Triglyceride-Glucose index group (≥9.125) had an increased risk of microalbuminuria compared to the low group (<9.125) with an adjusted odds ratio of 2.37 (95% CI 1.73-3.26).
Cohort (n=2,052)
No
Does a high Triglyceride-Glucose (TyG) index predict microalbuminuria in newly diagnosed, treatment-naïve patients with essential hypertension?
Estimación del efecto: OR 2.37 (95% CI 1.73-3.26)
Tasa de eventos absoluta: 32.6% vs 23.8%
valor p: p=<0.0001
Background The Triglyceride-Glucose (TyG) index has emerged as a potential predictor for microalbuminuria (MAU) in patients with essential hypertension. This study aims to assess the TyG index as a predictor of MAU in newly diagnosed hypertensive patients, using propensity score matching (PSM) to control for confounding factors. Methods A cohort of 2,052 newly diagnosed hypertensive patients from Changde Hospital, China (January 2020 to December 2024), was analyzed. The TyG index cutoff value was determined by receiver operating characteristic (ROC) analysis, with a value of 9.125. PSM was employed to balance baseline differences between low and high TyG index groups, and logistic regression models were used to analyze the association between TyG index and MAU. Subgroup analyses and sensitivity analyses were conducted to evaluate the robustness of the findings. Results In the final cohort, 2,052 patients were divided into two groups based on the optimal TyG index cutoff value of 9.125. After propensity score matching (PSM), the high TyG index group (≥9.125) exhibited significantly higher rates of MAU compared to the low TyG index group (9.125). In the adjusted models, the odds ratio (OR) for MAU in the high TyG index group was 2.37 (95% CI 1.73–3.26). The analysis revealed a non-linear, L-shaped association between TyG index and MAU, with a marked increase in the prevalence of MAU in the high TyG group. Sensitivity analyses, including inverse probability treatment weighting (IPTW), reinforced these findings, with the high TyG index group consistently showing a higher risk of MAU across both original and matched cohorts. Conclusions The TyG index is a simple and accessible biomarker for predicting MAU in newly diagnosed hypertensive patients, providing valuable insight for early detection of kidney damage in this population.
Wang et al. (Mon,) conducted a cohort in essential hypertension (n=2,052). Triglyceride-Glucose index vs. Low TyG index (<9.125) was evaluated on microalbuminuria (MAU) (OR 2.37, 95% CI 1.73-3.26, p=<0.0001). The high Triglyceride-Glucose index group (≥9.125) had an increased risk of microalbuminuria compared to the low group (<9.125) with an adjusted odds ratio of 2.37 (95% CI 1.73-3.26).